Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal cyclosporine A in chronic lung allograft dysfunction after single lung transplant
NCT03657342Phase 3Completed
- Sponsor
- Zambon
- Start
- Mar 2019
- Primary completion
- Apr 2024
- Modality
- Peptides, Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of liposomal cyclosporine A in Bronchiolitis Obliterans Syndrome (BOS), chronic lung allograft dysfunction (CLAD), sponsored by Zambon. Started Mar 2019; status: completed.
02
Drugs
liposomal cyclosporine A
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on NCT03657342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03657342.